Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
Clinical trial NCT05583708 · RECRUITING
Trial details
- NCT number
- NCT05583708
- Sponsor
- Weill Medical College of Cornell University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-03
- Primary completion
- 2028-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.